168 related articles for article (PubMed ID: 37923598)
21. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
[TBL] [Abstract][Full Text] [Related]
22. Liver metabolomics identifies bile acid profile changes at early stages of alcoholic liver disease in mice.
Charkoftaki G; Tan WY; Berrios-Carcamo P; Orlicky DJ; Golla JP; Garcia-Milian R; Aalizadeh R; Thomaidis NS; Thompson DC; Vasiliou V
Chem Biol Interact; 2022 Jun; 360():109931. PubMed ID: 35429548
[TBL] [Abstract][Full Text] [Related]
23. Could protein content of Urinary Extracellular Vesicles be useful to detect Cirrhosis in Alcoholic Liver Disease?
Gonzalez E; Azkargorta M; Garcia-Vallicrosa C; Prieto-Elordui J; Elortza F; Blanco-Sampascual S; Falcon-Perez JM
Int J Biol Sci; 2021; 17(8):1864-1877. PubMed ID: 34131392
[TBL] [Abstract][Full Text] [Related]
24. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
25. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease.
Maccioni L; Leclercq IA; Schnabl B; Stärkel P
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884492
[TBL] [Abstract][Full Text] [Related]
26. Ginseng fermentation solution affects the gut microbiota in zebrafish with alcoholic liver disease via PI3K/Akt pathway.
Wu Y; Liu S; Ren T; Ma L; Luo J; Zhang M; Li F; Dai Y; Zheng F; Pi Z; Yue H
Phytomedicine; 2024 Jun; 128():155495. PubMed ID: 38471317
[TBL] [Abstract][Full Text] [Related]
27. An integrated analysis of fecal microbiome and metabolomic features distinguish non-cirrhotic NASH from healthy control populations.
Carr RM; Li Y; Chau L; Friedman ES; Lee JJ; Adorini L; Erickson M; Zaru L; Shringarpure R; MacConell L; Bittinger K; Li H; Wu GD
Hepatology; 2023 Dec; 78(6):1843-1857. PubMed ID: 37222264
[TBL] [Abstract][Full Text] [Related]
28. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Kim DJ; Suk KT
Life Sci; 2023 Jun; 322():121626. PubMed ID: 37003543
[TBL] [Abstract][Full Text] [Related]
29. Targeted Metabolomics Identifies Differential Serum and Liver Amino Acids Biomarkers in Rats with Alcoholic Liver Disease.
Shi C; Wang L; Zhou K; Shao M; Lu Y; Wu T
J Nutr Sci Vitaminol (Tokyo); 2020; 66(6):536-544. PubMed ID: 33390395
[TBL] [Abstract][Full Text] [Related]
30. Gut Microbiota and Alcoholic Liver Disease.
Scarpellini E; Forlino M; Lupo M; Rasetti C; Fava G; Abenavoli L; De Santis A
Rev Recent Clin Trials; 2016; 11(3):213-9. PubMed ID: 27515958
[TBL] [Abstract][Full Text] [Related]
31. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?
Boye A; Zou YH; Yang Y
World J Gastroenterol; 2016 Jan; 22(1):50-71. PubMed ID: 26755860
[TBL] [Abstract][Full Text] [Related]
32. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
Manna SK; Thompson MD; Gonzalez FJ
Adv Exp Med Biol; 2015; 815():217-38. PubMed ID: 25427910
[TBL] [Abstract][Full Text] [Related]
33. Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease.
Taniai M; Hashimoto E; Tokushige K; Kodama K; Kogiso T; Torii N; Shiratori K
Hepatol Res; 2012 Apr; 42(4):359-67. PubMed ID: 22150916
[TBL] [Abstract][Full Text] [Related]
34. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
[TBL] [Abstract][Full Text] [Related]
35. Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis.
Shearn CT; Orlicky DJ; Saba LM; Shearn AH; Petersen DR
Free Radic Biol Med; 2015 Dec; 89():1144-53. PubMed ID: 26518673
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
[TBL] [Abstract][Full Text] [Related]
37. Carbohydrate-deficient transferrin as a marker of alcohol abuse: relationship to alcohol consumption, severity of liver disease, and fibrogenesis.
Niemelä O; Sorvajärvi K; Blake JE; Israel Y
Alcohol Clin Exp Res; 1995 Oct; 19(5):1203-8. PubMed ID: 8561291
[TBL] [Abstract][Full Text] [Related]
38. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
[TBL] [Abstract][Full Text] [Related]
39. Differential Metabolic Pathways and Metabolites in a C57BL/6J Mouse Model of Alcoholic Liver Disease.
Ma T; Li Y; Zhu Y; Jiang S; Cheng C; Peng Z; Xu L
Med Sci Monit; 2020 May; 26():e924602. PubMed ID: 32384076
[TBL] [Abstract][Full Text] [Related]
40. Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.
Shoreibah M; Raff E; Bloomer J; Kakati D; Rasheed K; Kuo YF; Singal AK
Ann Hepatol; 2016; 15(2):183-9. PubMed ID: 26845595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
